Antimitochondrial antibodies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
* '''Antimitochondrial antibodies''' (AMAs) are antibodies against mitochondrial antigens | * '''Antimitochondrial antibodies''' (AMAs) are antibodies against mitochondrial antigens | ||
| Line 65: | Line 65: | ||
== For Patients == | == For Patients == | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 22:20, 8 August 2012
| Antimitochondrial antibodies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
- Antimitochondrial antibodies (AMAs) are antibodies against mitochondrial antigens
Differential Diagnosis
Increased AMA
In alphabetical order: [1] [2]
- Chronic active hepatitis
- Combined primary biliary cirrhosis and arthralgias in women
- Cryptogenic cirrhosis
- Drug-induced lupus
- Polymyalgia Arthritis
- Primary Biliary Cirrhosis
- Rheumatoid Arthritis
Other Collagen Vascular Diseases
| TYPE | ASSOCIATION |
| AMA-M1 | Secondary Syphilis |
| AMA-M2 | Primary Biliary Cirrhosis |
| AMA-M3 | Drug-Induced Lupus |
| AMA-M4 | Hepatic Disorders |
| AMA-M5 | Systemic Lupus Erythematosus |
| AMA-M6 | Drug-Induced Hepatitis |
References
Acknowledgements
The content on this page was first contributed by Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
List of contributors: